Skip to main content

Main menu

  • Home
  • Content
    • Published Ahead of Print
    • Current Issue
    • Podcasts
    • Subject Collections
    • Archives
    • ASN Meeting Abstracts
    • Saved Searches
  • Authors
    • Submit a Manuscript
    • Author Resources
    • Reprint Information
  • Trainees
    • Peer Review Program
    • Prize Competition
  • About CJASN
    • About CJASN
    • Editorial Team
    • CJASN Impact
    • CJASN Recognitions
  • More
    • Alerts
    • Advertising
    • Reprint Information
    • Subscriptions
    • Feedback
  • ASN Kidney News
  • Other
    • JASN
    • Kidney360
    • Kidney News Online
    • American Society of Nephrology

User menu

  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
American Society of Nephrology
  • Other
    • JASN
    • Kidney360
    • Kidney News Online
    • American Society of Nephrology
  • Subscribe
  • My alerts
  • Log in
  • My Cart
Advertisement
American Society of Nephrology

Advanced Search

  • Home
  • Content
    • Published Ahead of Print
    • Current Issue
    • Podcasts
    • Subject Collections
    • Archives
    • ASN Meeting Abstracts
    • Saved Searches
  • Authors
    • Submit a Manuscript
    • Author Resources
    • Reprint Information
  • Trainees
    • Peer Review Program
    • Prize Competition
  • About CJASN
    • About CJASN
    • Editorial Team
    • CJASN Impact
    • CJASN Recognitions
  • More
    • Alerts
    • Advertising
    • Reprint Information
    • Subscriptions
    • Feedback
  • ASN Kidney News
  • Visit ASN on Facebook
  • Follow CJASN on Twitter
  • CJASN RSS
  • Community Forum
Original ArticlesAcute Kidney Injury /Acute Renal Failure
You have accessRestricted Access

Derivation of Urine Output Thresholds That Identify a Very High Risk of AKI in Patients with Septic Shock

David D. Leedahl, Erin N. Frazee, Garrett E. Schramm, Ross A. Dierkhising, Eric J. Bergstralh, Lakhmir S. Chawla and Kianoush B. Kashani
CJASN July 2014, 9 (7) 1168-1174; DOI: https://doi.org/10.2215/CJN.09360913
David D. Leedahl
*Pharmacy Services, Sanford Medical Center, Fargo, North Dakota;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Erin N. Frazee
†Pharmacy Services,
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Garrett E. Schramm
†Pharmacy Services,
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Ross A. Dierkhising
‡Division of Biomedical Statistics and Informatics, and
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Eric J. Bergstralh
‡Division of Biomedical Statistics and Informatics, and
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Lakhmir S. Chawla
§Department of Anesthesiology and Critical Care Medicine and Division of Renal Diseases and Hypertension, George Washington University Medical Center, Washington, DC
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Kianoush B. Kashani
‖Division of Nephrology and Hypertension and Division of Pulmonary and Critical Care Medicine, Mayo Clinic, Rochester, Minnesota; and
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Data Supps
  • Info & Metrics
  • View PDF
Loading

Abstract

Background and objectives To promote early detection of AKI, recently proposed pretest probability models combine sub–Kidney Disease Improving Global Outcomes (KDIGO) AKI criteria with baseline AKI risk. The primary objective of this study was to determine sub-KDIGO thresholds that identify patients with septic shock at highest risk for AKI.

Design, setting, participants, & measurements This was a retrospective analysis of 390 adult patients admitted to the medical intensive care unit (ICU) of a tertiary, academic medical center with septic shock between January 2008 and December 2010. Hourly urine output was collected from the time of septic shock recognition (hour 0) to hour 96, urine catheter removal, or ICU discharge (whichever occurred first). All available serum creatinine (SCr) measurements were collected until hour 96. The AKI pretest probability model was assessed during the first 12 hours of resuscitation and included the initial episode of oliguria, increase from baseline to peak SCr level, and Acute Physiology and Chronic Health Evaluation (APACHE) III score in a multivariable receiver-operator characteristic (ROC) analysis. The primary outcome was the incidence of stage II or III (stage II+) AKI defined by KDIGO criteria. Secondary outcomes included the need for RRT and 28-day mortality.

Results Ninety-eight (25%) patients developed stage II+ AKI after septic shock recognition. APACHE III score and increase in SCr level in the first 12 hours were not statistically associated with stage II+ AKI in multivariable ROC analysis. Consecutive oliguria for 3 hours had fair predictive ability for achieving stage II+ AKI criteria (area under ROC curve, 0.73; 95% confidence interval [95% CI], 0.68 to 0.78), and oliguria for 5 hours demonstrated optimal accuracy (82%; 95% CI, 79% to 86%).

Conclusions Three to 5 hours of consecutive oliguria in patients with septic shock may provide a valuable measure of AKI risk. Further validation to support this finding is needed.

  • Acute kidney injury
  • intensive care units
  • septic shock
  • kidney function tests
  • early diagnosis
  • clinical alarms

Introduction

Despite advances in the detection and treatment of AKI in critically ill patients, mortality from this condition remains alarmingly high (1–4). Among the array of renal failure causes, septic shock elicits particular concern: the incidence of AKI in this setting may exceed 60% (5,6). The combination of septic shock and AKI yields a nearly 2-fold risk of death compared with either alone (2,5). Therefore, tools for early detection of AKI in the septic patient are necessary to minimize delays in diagnosis and treatment.

Although definitions of AKI have varied historically, the Kidney Disease Improving Global Outcomes (KDIGO) working group has recently developed standard diagnostic criteria based on serum creatinine (SCr) and consecutive duration of oliguria (7,8). However, these criteria are difficult to interpret in a critically ill patient with varying SCr production and volume of distribution (9,10). Although the KDIGO urine output criterion requires >6 hours of oliguria for “risk of AKI” (stage I) and ≥12 hours of oliguria for stage II AKI, shorter durations are gaining clinical significance and may serve as an early clinical alarm for AKI (11–13).

The discovery of novel renal biomarkers and integration of real-time electronic alerts into clinical practice have reinvigorated interest in early detection of AKI (14,15). Unfortunately, routine use of these biomarker assays and electronic notification systems require significant clinical and financial resources. To enhance early, accessible, and cost-effective bedside identification of AKI risk in critical illness, experts have proposed the concept of renal angina (16–19). Renal angina is a conceptual clinical definition to operationalize and structure the pretest probability assessment for diagnosing AKI prospectively. The use of renal angina parallels the changing paradigm for many critical illnesses, wherein diagnoses pair radiographic imaging and laboratory evaluation with a patient’s pretest probability for a given disease state (20–22). The original renal angina concept categorized patients in one of three hazard levels based on a patient’s predisposition for AKI development (Supplemental Figure 1). Goldstein and Chawla proposed that adult patients with septic shock make up the highest risk hazard level for AKI. In other words, because of the high baseline risk associated with septic shock, minimal clinical evidence of kidney injury (sub-KDIGO evidence, known as adult renal angina [aRA]) should be used to identify patients at particular risk for the development of AKI (16). The proposed aRA model may facilitate earlier identification of AKI; however, this tool has yet to be derived or validated. Thus, we sought to derive the aRA model and characterize its ability to predict subsequent achievement of stage II or III (stage II+) AKI criteria among patients with septic shock.

Materials and Methods

Participant Identification

This retrospective analysis of a prospectively collected database examined adults with septic shock admitted to a 24-bed medical intensive care unit (ICU) at Mayo Clinic in Rochester, Minnesota, from January 2008 through December 2010 (23). The study ICU was staffed by a multidisciplinary team lead by intensivists 24/7 in house (24). The investigation was approved by the institutional review board with a waiver of informed consent and was performed in accordance with the ethical standards of the 1964 Declaration of Helsinki and its later amendments. We included patients older than 18 years of age with a systolic BP<90 mm Hg despite a fluid challenge of 20 ml/kg body weight of crystalloid or equivalent colloid, based on recommendations from the 2008 Surviving Sepsis Campaign (25). Treatment of septic shock was uniformly guided by our sepsis resuscitation bundle, which has been described previously (23). Exclusion criteria were applied in two stages to derive the study cohort (Figure 1). The first stage involved collection of data readily available by electronic query, and the second stage involved collection of data requiring manual abstraction or evaluation from the patient’s medical record. Patients having severe sepsis without shock, those with a history of ESRD, and those lacking research authorization were excluded from study eligibility. A random-number generator was used to select a subset of eligible patients who were then screened according to our study protocol (Figure 1).

Figure 1.
  • Download figure
  • Open in new tab
  • Download powerpoint
Figure 1.

A 390-patient cohort was included in the final analysis. ICD-9, International Classification of Diseases, Ninth Revision; KDIGO, Kidney Disease Improving Global Outcomes.

Study Protocol

Figure 2 illustrates our a priori–defined study protocol. To briefly summarize, patients were followed from septic shock recognition (hour 0) to hour 96. Hour 0 urine output was disregarded because of presumed retention of urine volume in the bladder at the time of catheterization. Urine output was recorded until ICU discharge, urinary catheter removal, or hour 96, whichever came first. The “aRA window” encompassed hours 1–12 wherein patients were assessed for the first episode of consecutive oliguria and baseline to peak SCr level increase. This cutoff point at hour 12 ensured that, by definition, patients would be unable to meet KDIGO stage II urine output criterion (>12 hours of oliguria) during the aRA window. To avoid including patients with early septic AKI, we excluded any individual who met KDIGO stage II SCr criterion (doubled SCr from baseline) from an initial SCr level within 12 hours from septic shock recognition. The primary outcome of stage II+ AKI and secondary outcome of RRT were analyzed at hour 96. All-cause mortality was assessed at 28 days.

Figure 2.
  • Download figure
  • Open in new tab
  • Download powerpoint
Figure 2.

Adult renal angina and AKI were assessed in a stepwise protocol. *KDIGO criteria by baseline to peak SCr level increase or consecutive oliguria. KDIGO, Kidney Disease Improving Global Outcomes; SCr, serum creatinine; UOP, urine output.

Data Collection and Definitions

Abstracted data pertained to demographic characteristics (age, sex, race, admission weight, comorbid conditions), severity of illness (Acute Physiology and Chronic Health Evaluation [APACHE] III score, vasopressor administration), and renal measures (urine output, SCr, RRT). Baseline SCr was calculated as the average of available SCr values within 6 months of hospitalization. When previous SCr values were not available, the lowest hospital SCr was used to estimate baseline renal function (26,27). Urine output was documented hourly in the electronic medical record after urinary catheter placement. Urine output charted as “0” was considered a true value. In the rare event that urine output charting was missing between hourly values, the subsequent recorded urine output value was divided evenly with the previous missing hours. To determine baseline to peak SCr level, the baseline SCr level was subtracted from the highest SCr level available in the first 12 hours after septic shock recognition. No formal criteria existed for RRT initiation during the study period. Use of RRT was per intensivist and attending nephrologist discretion and was individualized for each patient.

The time of septic shock recognition was defined according to the 2008 Surviving Sepsis Campaign consensus criteria at the time of documented hypotension despite 20 ml/kg crystalloid or equivalent colloid (28). No patients in the study received hydroxyethyl starch. If a colloid was used, it was 5% or 25% albumin. For patients transferred from outside hospitals with septic shock, the admission time was considered the time of septic shock recognition. To account for severity of illness, APACHE III scores were calculated upon ICU admission. Only the first episode of consecutive oliguria was evaluated, with oliguria defined as urine output<0.5 ml/kg per hour based on actual admission body weight (8,13). The primary outcome of stage II+ AKI was defined as achieving stage II or III KDIGO criteria (8).

Physician order priority (stat or routine) dictated the specimen type collected (plasma or serum) for creatinine measurement. Creatinine was measured using the standardized (isotope dilution mass spectrometry traceable) Roche enzymatic creatinine assay. For patients receiving intravenous catecholamine therapy, our institution used an isotope dilution mass spectrophotometry–traceable Roche rate–Jaffe creatinine assay (Roche Cobas Integra 400 Plus chemistry analyzer) to avoid interference with enzymatic assays.

Statistical Analyses

Categorical variables were summarized as frequencies (percentages). Continuous variables were expressed as medians with interquartile ranges. Assuming an approximate 30% overall incidence of stage II+ AKI and 25% exclusion rate with equal sample sizes, it was determined that an initial sample of 530 patients (400 included patients) would provide 99% power to detect a difference of 20% in the incidence of AKI between patients with and without aRA (depending on definition derived) (29). Univariate logistic regression was performed to analyze the association of the initial duration of consecutive oliguria, baseline to peak SCr level, and APACHE III score with the end points of stage II+ AKI, RRT, and 28-day mortality. A multivariable logistic regression model including all three variables was used to estimate the predictive contribution of all variables simultaneously. Two-way interactions were assessed and were not found to be statistically significant, so were not considered further. Receiver-operating characteristic (ROC) curves and the areas under the curves (AUCs) were used to assess discriminative power and are reported with 95% confidence intervals (95% CI). We defined an AUC of 0.5–0.6 as demonstrating no predictive ability, 0.6–0.7 as demonstrating poor predictive ability, 0.7–0.8 as demonstrating fair predictive ability, 0.8–0.9 as demonstrating good predictive ability, and >0.9 as demonstrating outstanding predictive ability (13). Binary prediction rules were applied to calculate sensitivity, specificity, accuracy, positive predictive value, and negative predictive value. Data were analyzed with SAS software, version 9.2 (SAS Institute Inc., Cary, NC).

Results

Three hundred ninety patients were included in the final analysis (Figure 1). Prehospitalization SCr was available for 86.7% of patients and was estimated in 13.3% (Table 1). At hour 96, 98 (25.1%) patients had achieved criteria for stage II+ AKI (58 patients stage II and 40 patients, stage III) and 33 (8.5%) had received RRT. Two patients received RRT after hour 96 (hours 167 and 174, respectively) and were not considered for the outcome of RRT by hour 96. Ninety-seven patients (24.9%) died by day 28.

View this table:
  • View inline
  • View popup
Table 1.

Baseline characteristics

Univariate logistic regression analysis revealed a statistically significant positive association between hours of consecutive oliguria and development of stage II+ AKI, need for RRT, and 28-day mortality. In contrast, baseline to peak SCr level increase was not associated with any outcome (Table 2). The multivariable model had good predictive ability for subsequently achieving stage II+ AKI criteria (AUC, 0.81; 95% CI, 0.76 to 0.87) and is included in Supplemental Figure 2. A sensitivity analysis that excluded patients in whom the baseline SCr was estimated by lowest hospital creatinine (n=52) yielded similar results (AUC, 0.80; 95% CI, 0.74 to 0.86) (Supplemental Figure 3). Excluding patients in septic shock transferred to the ICU from the emergency department or general ward (n=191) also demonstrated similar results (data not shown). No significant interaction was found between the requirement of vasopressors and consecutive oliguria for the outcome of stage II+ AKI by multiple logistic regression analysis (P=0.97). In the multivariable models for stage II+ AKI and need for RRT, consecutive oliguria was the sole variable with discriminatory power (Table 2).

View this table:
  • View inline
  • View popup
Table 2.

Univariate and multivariable logistic regression analyses (n=390)

Because the models suggested that consecutive oliguric hours was the only variable associated with stage II+ AKI, it was selected to define aRA (AUC, 0.82; 95% CI, 0.77 to 0.87). The ROC curve for a sensitivity analysis excluding patients without documented baseline SCr is displayed in Supplemental Figure 4. The discriminatory power of this tool, assessed by cutoff values for consecutive oliguria, is shown in Table 3. The cutoff of 5 hours maximized the sum of sensitivity and specificity, a suitable criterion to establish a good cutoff. Five hours of consecutive oliguria had good accuracy (82%; 95% CI, 79% to 86%) for prediction of subsequently achieving stage II+ AKI criteria with fair overall performance (AUC, 0.75; 95% CI, 0.69 to 0.80) (Table 4). However, 3 hours of oliguria achieved a similar overall performance (AUC, 0.73; 95% CI, 0.68 to 0.78) with an accuracy of 74% (95% CI, 70% to 78%). Patients who met criteria for the 3-hour oliguria cutoff received more fluid resuscitation than those who did not (1761 ml; 95% CI, 903 to 2618 ml; P<0.01). A scatterplot describing the association between fluid balance and oliguria duration, as well as our analysis of fluid balance for the 3- and 5-hour cutoff, may be found in Supplemental Figure 5 and Supplemental Table 1, respectively.

View this table:
  • View inline
  • View popup
Table 3.

Cutoff values for number of consecutive oliguric hours to predict achievement of stage II+ AKI criteria

View this table:
  • View inline
  • View popup
Table 4.

Comparison of 1-, 3-, and 5-hour cutoffs of consecutive oliguria for proposed adult renal angina definition to predict stage II+ AKI

Secondary ROC analyses, wherein the 3- and 5-hour cutoffs were analyzed for predictive ability to subsequently achieve any KDIGO AKI criteria (e.g., including stage I) are included in Supplemental Figures 6 and 7. To account for differences in relevant clinical variables between patients with and without aRA and between included and excluded patients, additional secondary analyses were performed and are summarized in Supplemental Figure 8 and Supplemental Tables 2–4.

Discussion

To our knowledge, the present study is the first known attempt to derive the oliguria component of aRA in septic shock. Before the findings of our investigation, alterations in urine output had been proposed as a sensitive marker for AKI in ICU patients (30). In addition, the novel concept of aRA had been proposed as a sub-KDIGO duration of consecutive oliguria and increase in SCr level over baseline in combination with a measure of illness severity (16). The original renal angina concept placed patients with septic shock in the “very high risk” hazard level, requiring only 1 hour of oliguria or a 0.1-mg/dl baseline to peak SCr level increase to achieve the proposed aRA definition (Supplemental Figure 1). We found that 3–5 hours of consecutive oliguria demonstrated the greatest predictive power for subsequent achievement of stage II+ AKI and was the most clinically useful definition of aRA in patients with septic shock. The results also suggested that baseline to peak SCr increase and APACHE III score negligibly influenced the model. As expected, APACHE III score remained significantly associated with 28-day mortality (Table 2). Therefore, our findings endorse the notion that pretest probability as assessed by aRA is not a severity-of-illness metric but rather an oliguria-based clinical alarm with potential to identify evolving AKI earlier in a patient’s clinical course.

A well designed, prospective multicenter trial by Prowle and colleagues has assessed the ability of consecutive oliguria to predict SCr-based AKI in critically ill patients (13). Our finding that 3–5 hours of consecutive oliguria is a reasonable definition for aRA is in agreement with Prowle and colleagues, who concluded that 4 hours of oliguria provided the best cumulative sensitivity and specificity for SCr-based AKI (52% and 86%, respectively). Our study expands on the work of Prowle and colleagues in several ways. Whereas their study looked at an oliguria-only variable for an SCr-based AKI outcome, we analyzed the association between both consecutive oliguria and SCr variables with the incidence of oliguria or SCr-based AKI. Prowle and colleagues evaluated a rather diverse 239-patient ICU population, whereas our study specifically evaluated a 390-patient cohort with septic shock treated uniformly with a bundled approach. The longest duration of consecutive oliguria on each day, used for analysis in Prowle and colleagues’ study, may be suboptimal for a clinical alarm. Because we desired to evaluate a tool to promote early identification of patients at high risk for AKI, we evaluated only the first episode of consecutive oliguria in the first 12 hours, simulating bedside assessment in real time.

Our findings agree with those of a recent study by Ralib and colleagues, who demonstrated that the current KDIGO definition of AKI may be too liberal in a general ICU population. In their analysis, a 6-hour urine output threshold of 0.3 ml/kg per hour yielded the optimal sensitivity and specificity for death or need for dialysis (61% and 77%, respectively). Our 3-hour urine output threshold of <0.5 ml/kg per hour in a septic shock population had similar predictive power for stage II+ AKI, need for dialysis, and 28-day mortality (31).

To our knowledge, this is the first published study that attempts to translate the aRA paradigm from theory to practice in adult patients with sepsis. The internal validity is strengthened by the homogeneity of our patient population and resuscitative efforts. All included patients were required to have documented systolic hypotension after a 20-ml/kg bolus (25). The 12-hour “aRA window” (Figure 2) and analysis of the first episode of consecutive oliguria was chosen to mimic assessment in the early phase of septic shock up to the KDIGO II urine output criterion (oliguria for >12 hours). Since timing of interventions is vital in septic shock and AKI, a 12-hour aRA cutoff simulates a time point where an intensivist may choose to provide additional interventions or observe. Finally, given the debate about the optimal end point for AKI, we chose the outcome of KDIGO stage II+ to analyze a severity of AKI that we deemed clearly clinically relevant.

Our study has several limitations. Urine output data were collected retrospectively and relied on accurate nurse charting, introducing the potential for inherent biases and unmeasured confounding variables. Although reflective of most clinical practices, SCr data were ordered at the discretion of the attending physician and relied on the measurements available for each patient. We cannot exclude the possibility that multiple measures of SCr or measuring SCr at the same time for each patient over the initial 12-hour window may have increased the predictive power of this variable for AKI. Fluid administration may have distorted SCr level measurements, but given the degree of fluid positivity in our patients, we anticipate at most a 0.1- to 0.2-mg/dl alteration in SCr would be present, which would not have meaningfully altered the findings (10). Diuretic use was not assessed because of the rare administration of such therapy to patients in the acute phase of shock. All patients receiving RRT had a primary renal indication (e.g., oliguria or anuria, hyperkalemia, fluid overload unresponsive to diuresis), but we cannot exclude the possibility that undetected or undocumented differences in the criteria to start RRT in our study may have influenced the results. We must also emphasize that we evaluated a patient cohort from the “very high risk” hazard level for aRA, and our definition does not apply to patient populations from lower hazard levels. This retrospective analysis of a prospectively collected septic shock cohort was conducted at a single ICU with predominantly white patients, and our definition of aRA from this study may not be generalizable to patients with different clinical scenarios, practice environments, or baseline risk factors for AKI. We feel it is important to address the position of aRA among other tools for AKI prediction, such as the renal angina index, which has been recently validated in a pediatric cohort (19). It is important to recognize that the concept of renal angina is subdivided into aRA and pediatric renal angina (pRA). The rationale for this distinction is based on the fact that the pediatric criteria use fluid overload and do not define AKI or pediatric renal angina using urine output. Although our findings demonstrated a statistical relationship between increased fluid overload and duration of oliguria, we cannot exclude the possibility that additional AKI risk factors (e.g., fluid balance) may have significantly contributed to AKI, RRT, or mortality in the aRA model (Supplemental Figure 5). However, the aRA criteria used in this study were congruent with the original aRA concept and KDIGO classification schema.

Our model of aRA provides an array of potential strengths. While most components of risk stratification are static (e.g., comorbid conditions, demographic characteristics, resuscitation measures), our proposed aRA definition of 3–5 hours of consecutive oliguria during the initial 12 hours after septic shock recognition provides a dynamic and responsive tool for the intensivist. Urine output is readily assessed at the bedside and already routinely collected, posing no additional laboratory costs. Our study promotes a culture of recording and reporting changes in hourly urine output for critically ill patients. If hourly urine output is documented, electronic alert mechanisms could be developed to actively survey for oliguria and facilitate patient assessment, fluid or vasopressor administration, nephrology specialist consultation, or early RRT before additional biochemical evidence of AKI is observed (32,33). Evaluating pretest probability using a 3-hour oliguria cutoff may aid in the decision to deploy other diagnostic tests (e.g., AKI biomarkers), potentially increasing their accuracy and cost-effectiveness (34). Finally, our definition of aRA may add value to an existing or investigational risk score for AKI in the ICU (35,36).

In conclusion, 3–5 hours of consecutive oliguria within 12 hours after septic shock recognition may provide a valuable measure of AKI risk. In practice, this would mean that once a patient with septic shock develops 3 hours of consecutive oliguria, the patient has adult renal angina. Further validation to support the proposed definition is needed.

Disclosures

None.

Acknowledgments

The authors thank Dr. Stuart Goldstein for his critical review of the manuscript for intellectual content. They also acknowledge the late Dr. Bekele Afessa for his expert guidance in database development and help with data collection.

Discretionary funds for statistical efforts were provided by Mayo Clinic Pharmacy Services.

Footnotes

  • Published online ahead of print. Publication date available at www.cjasn.org.

  • This article contains supplemental material online at http://cjasn.asnjournals.org/lookup/suppl/doi:10.2215/CJN.09360913/-/DCSupplemental.

  • Received September 9, 2013.
  • Accepted March 19, 2014.
  • Copyright © 2014 by the American Society of Nephrology

References

  1. ↵
    1. Hoste EA,
    2. Schurgers M
    : Epidemiology of acute kidney injury: How big is the problem? Crit Care Med 36[Suppl]: S146–S151, 2008pmid:18382186
    OpenUrlCrossRefPubMed
  2. ↵
    1. Oppert M,
    2. Engel C,
    3. Brunkhorst FM,
    4. Bogatsch H,
    5. Reinhart K,
    6. Frei U,
    7. Eckardt KU,
    8. Loeffler M,
    9. John S,
    10. German Competence Network Sepsis (Sepnet)
    : Acute renal failure in patients with severe sepsis and septic shock—a significant independent risk factor for mortality: Results from the German Prevalence Study. Nephrol Dial Transplant 23: 904–909, 2008pmid:18065435
    OpenUrlCrossRefPubMed
    1. Uchino S,
    2. Kellum JA,
    3. Bellomo R,
    4. Doig GS,
    5. Morimatsu H,
    6. Morgera S,
    7. Schetz M,
    8. Tan I,
    9. Bouman C,
    10. Macedo E,
    11. Gibney N,
    12. Tolwani A,
    13. Ronco C,
    14. Beginning and Ending Supportive Therapy for the Kidney (BEST Kidney) Investigators
    : Acute renal failure in critically ill patients: A multinational, multicenter study. JAMA 294: 813–818, 2005pmid:16106006
    OpenUrlCrossRefPubMed
  3. ↵
    1. Bouchard J,
    2. Soroko SB,
    3. Chertow GM,
    4. Himmelfarb J,
    5. Ikizler TA,
    6. Paganini EP,
    7. Mehta RL,
    8. Program to Improve Care in Acute Renal Disease (PICARD) Study Group
    : Fluid accumulation, survival and recovery of kidney function in critically ill patients with acute kidney injury. Kidney Int 76: 422–427, 2009pmid:19436332
    OpenUrlCrossRefPubMed
  4. ↵
    1. Bagshaw SM,
    2. Lapinsky S,
    3. Dial S,
    4. Arabi Y,
    5. Dodek P,
    6. Wood G,
    7. Ellis P,
    8. Guzman J,
    9. Marshall J,
    10. Parrillo JE,
    11. Skrobik Y,
    12. Kumar A,
    13. Cooperative Antimicrobial Therapy of Septic Shock (CATSS) Database Research Group
    : Acute kidney injury in septic shock: Clinical outcomes and impact of duration of hypotension prior to initiation of antimicrobial therapy. Intensive Care Med 35: 871–881, 2009pmid:19066848
    OpenUrlCrossRefPubMed
  5. ↵
    1. Kim WY,
    2. Huh JW,
    3. Lim CM,
    4. Koh Y,
    5. Hong SB
    : A comparison of acute kidney injury classifications in patients with severe sepsis and septic shock. Am J Med Sci 344: 350–356, 2012pmid:22261626
    OpenUrlPubMed
  6. ↵
    1. Palevsky PM,
    2. Liu KD,
    3. Brophy PD,
    4. Chawla LS,
    5. Parikh CR,
    6. Thakar CV,
    7. Tolwani AJ,
    8. Waikar SS,
    9. Weisbord SD
    : KDOQI US commentary on the 2012 KDIGO clinical practice guideline for acute kidney injury. Am J Kidney Dis 61: 649–672, 2013pmid:23499048
    OpenUrlCrossRefPubMed
  7. ↵
    1. Kidney Disease,
    2. Improving Global Outcomes (KDIGO) Acute Kidney Injury Work Group
    : KDIGO Clinical Practice Guideline for Acute Kidney Injury. Kidney Int Suppl 2: 1–138, 2012
    OpenUrlCrossRefPubMed
  8. ↵
    1. Kassirer JP
    : Clinical evaluation of kidney function—glomerular function. N Engl J Med 285: 385–389, 1971pmid:4933769
    OpenUrlCrossRefPubMed
  9. ↵
    1. Macedo E,
    2. Bouchard J,
    3. Soroko SH,
    4. Chertow GM,
    5. Himmelfarb J,
    6. Ikizler TA,
    7. Paganini EP,
    8. Mehta RL,
    9. Program to Improve Care in Acute Renal Disease Study
    : Fluid accumulation, recognition and staging of acute kidney injury in critically-ill patients. Crit Care 14: R82, 2010pmid:20459609
    OpenUrlCrossRefPubMed
  10. ↵
    1. Robert S,
    2. Zarowitz BJ
    : Is there a reliable index of glomerular filtration rate in critically ill patients? DICP 25: 169–178, 1991pmid:2058189
    OpenUrlCrossRefPubMed
    1. Doi K,
    2. Yuen PS,
    3. Eisner C,
    4. Hu X,
    5. Leelahavanichkul A,
    6. Schnermann J,
    7. Star RA
    : Reduced production of creatinine limits its use as marker of kidney injury in sepsis. J Am Soc Nephrol 20: 1217–1221, 2009pmid:19389851
    OpenUrlAbstract/FREE Full Text
  11. ↵
    1. Prowle JR,
    2. Liu YL,
    3. Licari E,
    4. Bagshaw SM,
    5. Egi M,
    6. Haase M,
    7. Haase-Fielitz A,
    8. Kellum JA,
    9. Cruz D,
    10. Ronco C,
    11. Tsutsui K,
    12. Uchino S,
    13. Bellomo R
    : Oliguria as predictive biomarker of acute kidney injury in critically ill patients. Crit Care 15: R172, 2011pmid:21771324
    OpenUrlCrossRefPubMed
  12. ↵
    1. Colpaert K,
    2. Hoste EA,
    3. Steurbaut K,
    4. Benoit D,
    5. Van Hoecke S,
    6. De Turck F,
    7. Decruyenaere J
    : Impact of real-time electronic alerting of acute kidney injury on therapeutic intervention and progression of RIFLE class. Crit Care Med 40: 1164–1170, 2012pmid:22067631
    OpenUrlCrossRefPubMed
  13. ↵
    1. Schilcher G,
    2. Ribitsch W,
    3. Otto R,
    4. Portugaller RH,
    5. Quehenberger F,
    6. Truschnig-Wilders M,
    7. Zweiker R,
    8. Stiegler P,
    9. Brodmann M,
    10. Weinhandl K,
    11. Horina JH
    : Early detection and intervention using neutrophil gelatinase-associated lipocalin (NGAL) may improve renal outcome of acute contrast media induced nephropathy: A randomized controlled trial in patients undergoing intra-arterial angiography (ANTI-CIN Study). BMC Nephrol 12: 39, 2011pmid:21849080
    OpenUrlCrossRefPubMed
  14. ↵
    1. Goldstein SL,
    2. Chawla LS
    : Renal angina. Clin J Am Soc Nephrol 5: 943–949, 2010pmid:20299370
    OpenUrlAbstract/FREE Full Text
    1. Goldstein SL
    : Acute kidney injury biomarkers: Renal angina and the need for a renal troponin I. BMC Med 9: 135, 2011pmid:22189039
    OpenUrlCrossRefPubMed
    1. Basu RK,
    2. Chawla LS,
    3. Wheeler DS,
    4. Goldstein SL
    : Renal angina: An emerging paradigm to identify children at risk for acute kidney injury. Pediatr Nephrol 27: 1067–1078, 2012pmid:22012033
    OpenUrlCrossRefPubMed
  15. ↵
    1. Basu RK,
    2. Zappitelli M,
    3. Brunner L,
    4. Wang Y,
    5. Wong HR,
    6. Chawla LS,
    7. Wheeler DS,
    8. Goldstein SL
    : Derivation and validation of the renal angina index to improve the prediction of acute kidney injury in critically ill children. Kidney Int 85: 659–667, 2014pmid:24048379
    OpenUrlCrossRefPubMed
  16. ↵
    1. Cook DJ,
    2. Donadini MP
    : Pulmonary embolism in medical-surgical critically ill patients. Hematol Oncol Clin North Am 24: 677–682, vii, 2010
    OpenUrlCrossRefPubMed
    1. Lauzier F,
    2. Ruest A,
    3. Cook D,
    4. Dodek P,
    5. Albert M,
    6. Shorr AF,
    7. Day A,
    8. Jiang X,
    9. Heyland D,
    10. Canadian Critical Care Trials Group
    : The value of pretest probability and modified clinical pulmonary infection score to diagnose ventilator-associated pneumonia. J Crit Care 23: 50–57, 2008pmid:18359421
    OpenUrlCrossRefPubMed
  17. ↵
    1. Ranieri VM,
    2. Rubenfeld GD,
    3. Thompson BT,
    4. Ferguson ND,
    5. Caldwell E,
    6. Fan E,
    7. Camporota L,
    8. Slutsky AS,
    9. ARDS Definition Task Force
    : Acute respiratory distress syndrome: The Berlin Definition. JAMA 307: 2526–2533, 2012pmid:22797452
    OpenUrlCrossRefPubMed
  18. ↵
    1. Schramm GE,
    2. Kashyap R,
    3. Mullon JJ,
    4. Gajic O,
    5. Afessa B
    : Septic shock: A multidisciplinary response team and weekly feedback to clinicians improve the process of care and mortality. Crit Care Med 39: 252–258, 2011pmid:21057312
    OpenUrlCrossRefPubMed
  19. ↵
    1. Gajic O,
    2. Afessa B,
    3. Hanson AC,
    4. Krpata T,
    5. Yilmaz M,
    6. Mohamed SF,
    7. Rabatin JT,
    8. Evenson LK,
    9. Aksamit TR,
    10. Peters SG,
    11. Hubmayr RD,
    12. Wylam ME
    : Effect of 24-hour mandatory versus on-demand critical care specialist presence on quality of care and family and provider satisfaction in the intensive care unit of a teaching hospital. Crit Care Med 36: 36–44, 2008pmid:18007270
    OpenUrlCrossRefPubMed
  20. ↵
    1. Dellinger RP,
    2. Levy MM,
    3. Carlet JM,
    4. Bion J,
    5. Parker MM,
    6. Jaeschke R,
    7. Reinhart K,
    8. Angus DC,
    9. Brun-Buisson C,
    10. Beale R,
    11. Calandra T,
    12. Dhainaut JF,
    13. Gerlach H,
    14. Harvey M,
    15. Marini JJ,
    16. Marshall J,
    17. Ranieri M,
    18. Ramsay G,
    19. Sevransky J,
    20. Thompson BT,
    21. Townsend S,
    22. Vender JS,
    23. Zimmerman JL,
    24. Vincent JL,
    25. International Surviving Sepsis Campaign Guidelines Committee,
    26. American Association of Critical-Care Nurses,
    27. American College of Chest Physicians,
    28. American College of Emergency Physicians,
    29. Canadian Critical Care Society,
    30. European Society of Clinical Microbiology and Infectious Diseases,
    31. European Society of Intensive Care Medicine,
    32. European Respiratory Society,
    33. International Sepsis Forum,
    34. Japanese Association for Acute Medicine,
    35. Japanese Society of Intensive Care Medicine,
    36. Society of Critical Care Medicine,
    37. Society of Hospital Medicine,
    38. Surgical Infection Society,
    39. World Federation of Societies of Intensive and Critical Care Medicine
    : Surviving Sepsis Campaign: International guidelines for management of severe sepsis and septic shock: 2008. Crit Care Med 36: 296–327, 2008pmid:18158437
    OpenUrlCrossRefPubMed
  21. ↵
    1. Siew ED,
    2. Matheny ME,
    3. Ikizler TA,
    4. Lewis JB,
    5. Miller RA,
    6. Waitman LR,
    7. Go AS,
    8. Parikh CR,
    9. Peterson JF
    : Commonly used surrogates for baseline renal function affect the classification and prognosis of acute kidney injury. Kidney Int 77: 536–542, 2010pmid:20042998
    OpenUrlCrossRefPubMed
  22. ↵
    1. Lafrance JP,
    2. Miller DR
    : Defining acute kidney injury in database studies: The effects of varying the baseline kidney function assessment period and considering CKD status. Am J Kidney Dis 56: 651–660, 2010pmid:20673605
    OpenUrlCrossRefPubMed
  23. ↵
    1. Bone RC,
    2. Balk RA,
    3. Cerra FB,
    4. Dellinger RP,
    5. Fein AM,
    6. Knaus WA,
    7. Schein RM,
    8. Sibbald WJ,
    9. The ACCP/SCCM Consensus Conference Committee. American College of Chest Physicians/Society of Critical Care Medicine
    : Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. Chest 101: 1644–1655, 1992pmid:1303622
    OpenUrlCrossRefPubMed
  24. ↵
    1. Suh SH,
    2. Kim CS,
    3. Choi JS,
    4. Bae EH,
    5. Ma SK,
    6. Kim SW
    : Acute kidney injury in patients with sepsis and septic shock: Risk factors and clinical outcomes. Yonsei Med J 54: 965–972, 2013pmid:23709433
    OpenUrlCrossRefPubMed
  25. ↵
    1. Macedo E,
    2. Malhotra R,
    3. Claure-Del Granado R,
    4. Fedullo P,
    5. Mehta RL
    : Defining urine output criterion for acute kidney injury in critically ill patients. Nephrol Dial Transplant 26: 509–515, 2011
    OpenUrlCrossRefPubMed
  26. ↵
    1. Md Ralib A,
    2. Pickering JW,
    3. Shaw GM,
    4. Endre ZH
    : The urine output definition of acute kidney injury is too liberal. Crit Care 17: R112, 2013pmid:23787055
    OpenUrlCrossRefPubMed
  27. ↵
    1. Karvellas CJ,
    2. Farhat MR,
    3. Sajjad I,
    4. Mogensen SS,
    5. Leung AA,
    6. Wald R,
    7. Bagshaw SM
    : A comparison of early versus late initiation of renal replacement therapy in critically ill patients with acute kidney injury: A systematic review and meta-analysis. Crit Care 15: R72, 2011pmid:21352532
    OpenUrlCrossRefPubMed
  28. ↵
    1. Ponce D,
    2. Zorzenon Cde P,
    3. dos Santos NY,
    4. Balbi AL
    : Early nephrology consultation can have an impact on outcome of acute kidney injury patients. Nephrol Dial Transplant 26: 3202–3206, 2011
    OpenUrlCrossRefPubMed
  29. ↵
    1. de Geus HR,
    2. Betjes MG,
    3. Bakker J
    : Biomarkers for the prediction of acute kidney injury: a narrative review on current status and future challenges. Clin Kidney J 5: 102–108, 2012
    OpenUrlCrossRefPubMed
  30. ↵
    1. Cartin-Ceba R,
    2. Kashiouris M,
    3. Plataki M,
    4. Kor DJ,
    5. Gajic O,
    6. Casey ET
    : Risk factors for development of acute kidney injury in critically ill patients: A systematic review and meta-analysis of observational studies. Crit Care Res Pract 2012: 691013, 2012pmid:23227318
    OpenUrlCrossRefPubMed
  31. ↵
    1. Demirjian S,
    2. Schold JD,
    3. Navia J,
    4. Mastracci TM,
    5. Paganini EP,
    6. Yared JP,
    7. Bashour CA
    : Predictive models for acute kidney injury following cardiac surgery. Am J Kidney Dis 59: 382–389, 2012
    OpenUrlCrossRefPubMed
View Abstract
PreviousNext
Back to top

In this issue

Clinical Journal of the American Society of Nephrology: 9 (7)
Clinical Journal of the American Society of Nephrology
Vol. 9, Issue 7
July 07, 2014
  • Table of Contents
  • Table of Contents (PDF)
  • Index by author
View Selected Citations (0)
Print
Download PDF
Sign up for Alerts
Email Article
Thank you for your help in sharing the high-quality science in CJASN.
Enter multiple addresses on separate lines or separate them with commas.
Derivation of Urine Output Thresholds That Identify a Very High Risk of AKI in Patients with Septic Shock
(Your Name) has sent you a message from American Society of Nephrology
(Your Name) thought you would like to see the American Society of Nephrology web site.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
Derivation of Urine Output Thresholds That Identify a Very High Risk of AKI in Patients with Septic Shock
David D. Leedahl, Erin N. Frazee, Garrett E. Schramm, Ross A. Dierkhising, Eric J. Bergstralh, Lakhmir S. Chawla, Kianoush B. Kashani
CJASN Jul 2014, 9 (7) 1168-1174; DOI: 10.2215/CJN.09360913

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Request Permissions
Share
Derivation of Urine Output Thresholds That Identify a Very High Risk of AKI in Patients with Septic Shock
David D. Leedahl, Erin N. Frazee, Garrett E. Schramm, Ross A. Dierkhising, Eric J. Bergstralh, Lakhmir S. Chawla, Kianoush B. Kashani
CJASN Jul 2014, 9 (7) 1168-1174; DOI: 10.2215/CJN.09360913
del.icio.us logo Digg logo Reddit logo Twitter logo CiteULike logo Facebook logo Google logo Mendeley logo
  • Tweet Widget
  • Facebook Like

Jump to section

  • Article
    • Abstract
    • Introduction
    • Materials and Methods
    • Results
    • Discussion
    • Disclosures
    • Acknowledgments
    • Footnotes
    • References
  • Figures & Data Supps
  • Info & Metrics
  • View PDF

More in this TOC Section

Original Articles

  • Availability, Accessibility, and Quality of Conservative Kidney Management Worldwide
  • Zolpidem Versus Trazodone Initiation and the Risk of Fall-Related Fractures among Individuals Receiving Maintenance Hemodialysis
  • Network Meta-Analysis of Novel Glucose-Lowering Drugs on Risk of Acute Kidney Injury
Show more Original Articles

Acute Kidney Injury /Acute Renal Failure

  • Acute Respiratory Distress Syndrome and Risk of AKI among Critically Ill Patients
  • Methodologic Issues in the Measurement of Urinary Renin
Show more Acute Kidney Injury /Acute Renal Failure

Cited By...

  • No citing articles found.
  • Google Scholar

Similar Articles

Related Articles

  • PubMed
  • Google Scholar

Keywords

  • acute kidney injury
  • intensive care units
  • septic shock
  • Kidney Function Tests
  • Early Diagnosis
  • clinical alarms

Articles

  • Current Issue
  • Early Access
  • Subject Collections
  • Article Archive
  • ASN Meeting Abstracts

Information for Authors

  • Submit a Manuscript
  • Trainee of the Year
  • Author Resources
  • ASN Journal Policies
  • Reuse/Reprint Policy

About

  • CJASN
  • ASN
  • ASN Journals
  • ASN Kidney News

Journal Information

  • About CJASN
  • CJASN Email Alerts
  • CJASN Key Impact Information
  • CJASN Podcasts
  • CJASN RSS Feeds
  • Editorial Board

More Information

  • Advertise
  • ASN Podcasts
  • ASN Publications
  • Become an ASN Member
  • Feedback
  • Follow on Twitter
  • Password/Email Address Changes
  • Subscribe

© 2021 American Society of Nephrology

Print ISSN - 1555-9041 Online ISSN - 1555-905X

Powered by HighWire